Blood Component Therapies
This is a contract result notice, not an open opportunity. Details from the official award data.
This is a large award for Research & Development — above three-quarters of comparable contracts. Based on 20,405 valued Research & Development tenders in our corpus.
The Institution will provide the required laboratory facilities and technical support in order for the Principal Investigator to conduct research in order to answer the following objectives: a.
Evaluate clot structure and stability in clots formed from whole blood vs. red blood cell, plasma and platelet component therapy b.
How do additive and storage solutions used to stabilise red blood cell and platelet component therapies alter clot structure and stability? c.
How does cold or warm storage of blood products alter clot structure and stability
What the supplier must deliver
The Institution will provide the required laboratory
The Institution will provide the required laboratory facilities and technical support in order for the Principal Investigator to conduct research in order to answer the following objectives:.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at MINISTRY OF DEFENCE, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- c2e6a7ca-81e7-4339-97e7-c0ae5908c14d
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- 707947456
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
MINISTRY OF DEFENCE’s tender network
Assembling the network…